Xiehui Chen

987 total citations · 1 hit paper
33 papers, 608 citations indexed

About

Xiehui Chen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Xiehui Chen has authored 33 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Xiehui Chen's work include Atrial Fibrillation Management and Outcomes (3 papers), Cardiovascular Function and Risk Factors (3 papers) and MicroRNA in disease regulation (3 papers). Xiehui Chen is often cited by papers focused on Atrial Fibrillation Management and Outcomes (3 papers), Cardiovascular Function and Risk Factors (3 papers) and MicroRNA in disease regulation (3 papers). Xiehui Chen collaborates with scholars based in China, Japan and United States. Xiehui Chen's co-authors include Yufeng Zheng, Donghui Zhu, Hongtao Yang, Liqun Ruan, Jianan Yang, Kazuki Takashima, Guannan Li, Wenqin Guo, Xiao‐Qing Quan and Xinyi Wei and has published in prestigious journals such as FEBS Letters, Frontiers in Immunology and Acta Biomaterialia.

In The Last Decade

Xiehui Chen

29 papers receiving 602 citations

Hit Papers

Association between the stress hyperglycemia ratio and 28... 2024 2026 2025 2024 25 50 75

Peers

Xiehui Chen
Shi Jin China
Saptarshi Kar United States
Young Bum Kim South Korea
Yizhe Wu China
Ching-Hsin Ku United Kingdom
Xiehui Chen
Citations per year, relative to Xiehui Chen Xiehui Chen (= 1×) peers Shaobin Jia

Countries citing papers authored by Xiehui Chen

Since Specialization
Citations

This map shows the geographic impact of Xiehui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiehui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiehui Chen more than expected).

Fields of papers citing papers by Xiehui Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiehui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiehui Chen. The network helps show where Xiehui Chen may publish in the future.

Co-authorship network of co-authors of Xiehui Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiehui Chen. A scholar is included among the top collaborators of Xiehui Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiehui Chen. Xiehui Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yanli, Xinyu Wu, Mingcan Yang, et al.. (2025). Immunophenotypic Profiling Reveals Circulating Lymphocyte Dysregulation in Primary Sjögren's Syndrome. International Journal of Rheumatic Diseases. 28(6). e70276–e70276.
2.
Li-zhi, Cheng, Xu-Yang Li, Yifei Li, et al.. (2024). Four new guaiane sesquiterpenes from Agarwood of Aquilaria sinensis and their biological activity toward renal fibrosis. Fitoterapia. 178. 106143–106143.
3.
Xie, Jiaqi, Jiaqi Liu, Xiehui Chen, & Changchun Zeng. (2024). Purinosomes involved in the regulation of tumor metabolism: current progress and potential application targets. Frontiers in Oncology. 14. 1333822–1333822. 6 indexed citations
4.
Shao, Yijia, Fang Wu, Xiao‐Qing Quan, et al.. (2024). Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension. Microbiological Research. 287. 127824–127824. 13 indexed citations
5.
Chen, Xiehui & Changchun Zeng. (2024). Pioneering the Way: The Revolutionary Potential of Antibody–Drug Conjugates in NSCLC. Current Treatment Options in Oncology. 25(4). 556–584. 2 indexed citations
6.
Tian, Pengfei, Jua Kim, Xian Li, et al.. (2023). Dual stimulus responsive borosilicate glass (BSG) scaffolds promote diabetic alveolar bone defectsrepair by modulating macrophage phenotype. Bioactive Materials. 26. 231–248. 41 indexed citations
7.
Yan, Fengjuan, et al.. (2023). Development and validation of an interpretable machine learning model—Predicting mild cognitive impairment in a high-risk stroke population. Frontiers in Aging Neuroscience. 15. 1180351–1180351. 8 indexed citations
8.
Shen, Shutong, Fei Xu, Xiehui Chen, et al.. (2022). Highly Purified Eicosapentaenoic Acid Alleviates the Inflammatory Response and Oxidative Stress in Macrophages during Atherosclerosis via the miR‐1a‐3p/sFRP1/Wnt/PCP‐JNK Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 9451058–9451058. 7 indexed citations
9.
Zhao, Limin, Xiehui Chen, & Mei Qiu. (2022). Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 12. 825100–825100. 2 indexed citations
10.
Chen, Xiehui, Shanshan Li, Ayodeji Bello, et al.. (2022). Mechanism of differential expression of β-glucosidase genes in functional microbial communities in response to carbon catabolite repression. Biotechnology for Biofuels and Bioproducts. 15(1). 3–3. 12 indexed citations
11.
13.
Chen, Xiehui, et al.. (2021). Anti-hyperlipidemic, Anti-inflammatory, and Ameliorative Effects of DRP1 Inhibition in Rats with Experimentally Induced Myocardial Infarction. Cardiovascular Toxicology. 21(12). 1000–1011. 7 indexed citations
14.
Chen, Xiehui, et al.. (2021). Relationship Between the Eosinophil/Monocyte Ratio and Prognosis in Decompensated Heart Failure: A Retrospective Study. Journal of Inflammation Research. Volume 14. 4687–4696. 8 indexed citations
15.
Chen, Xiehui, et al.. (2021). Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis. Thrombosis Journal. 19(1). 69–69. 9 indexed citations
16.
Guo, Jun, Chunxiao Yang, Yajun Lin, et al.. (2020). Enhanced peripheral blood miR-324-5p is associated with the risk of metabolic syndrome by suppressing ROCK1. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(8). 158727–158727. 6 indexed citations
17.
Guo, Wenqin, et al.. (2020). Association Between Base Excess and Mortality in Patients with Congestive Heart Failure. ESC Heart Failure. 8(1). 250–258. 15 indexed citations
18.
Luo, Ying, Li Xie, Honglei Zhao, et al.. (2020). Activation of the CaR-CSE/H2S pathway confers cardioprotection against ischemia-reperfusion injury. Experimental Cell Research. 398(2). 112389–112389. 6 indexed citations
19.
Li, Guannan, Hongtao Yang, Yufeng Zheng, et al.. (2019). Challenges in the use of zinc and its alloys as biodegradable metals: Perspective from biomechanical compatibility. Acta Biomaterialia. 97. 23–45. 239 indexed citations
20.
Wang, Shuyue, Linfang Li, Xiehui Chen, et al.. (2018). miR‑338‑3p mediates gluconeogenesis via targeting of PP4R1 in hepatocytes. Molecular Medicine Reports. 18(4). 4129–4137. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026